Health

Medical Breakthrough: Low-Cost Antidepressant Found to Combat Long COVID Fatigue

Researchers find that the low-cost antidepressant fluvoxamine significantly reduces fatigue in long COVID patients, offering a major breakthrough for millions.

Published

2 months ago

on

A Major Advance in Long COVID Treatment

A global research team co-led by McMaster University has announced a significant breakthrough in the treatment of long COVID, identifying one of the first medications proven to meaningfully reduce persistent fatigue. According to a randomized, placebo-controlled clinical trial published in the Annals of Internal Medicine, the widely available antidepressant fluvoxamine significantly improved both energy levels and the overall quality of life for patients struggling with the long-term effects of the virus.

Fatigue remains the most debilitating symptom for the estimated 65 million people living with long COVID worldwide. For many, the exhaustion is so profound that it prevents them from returning to work or engaging in daily family activities. Despite the scale of the crisis, medical guidelines have largely been limited to supportive care and pacing due to a lack of evidence-based pharmacological options.

The REVIVE-TOGETHER Trial Results

The study, known as the REVIVE-TOGETHER trial, involved 399 adults in Brazil who had experienced persistent fatigue for at least 90 days following a COVID-19 infection. Participants were randomly assigned to receive either fluvoxamine, the diabetes medication metformin, or a placebo for 60 days. The results were stark: researchers found a 99 percent probability that fluvoxamine outperformed the placebo in reducing fatigue. Conversely, while metformin has previously shown promise in preventing long COVID if taken during the initial infection, it offered no meaningful benefit for those with established fatigue symptoms.

“This is an important step forward for patients who have been desperate for evidence-based options,” said Edward Mills, senior author and professor at McMaster University. He noted that because fluvoxamine is already widely used and well-understood by the medical community, it has immediate potential for clinical application.

Innovation in Clinical Research

Beyond the discovery of the drug’s efficacy, the trial was notable for its sophisticated Bayesian adaptive design. This allowed the international team—comprising researchers from Stanford, UBC, Duke, and several Brazilian institutions—to reach conclusions more efficiently than traditional trials. The study was able to stop specific treatment arms once the evidence became clear, accelerating the delivery of much-needed data to the public.

While experts emphasize that long COVID is a complex condition that may require multiple treatment pathways, the identification of fluvoxamine provides clinicians with the first strong evidence for a medication that targets the condition’s most common symptom. Further research is expected to determine which specific patient profiles benefit most from the treatment.

Related Topics:
Continue Reading

Health

Beyond the Caffeine Buzz: How Coffee Harmonizes Your Gut and Brain Health

New research from University College Cork reveals how coffee improves gut bacteria, reduces inflammation, and boosts brain health via the gut-brain axis.

Published

3 days ago

on

May 30, 2026

By

The Powerful Connection Between Your Cup and Your Core

For millions, the morning coffee ritual is a non-negotiable start to the day. However, new research is revealing that the benefits of this global staple extend far beyond a simple energy boost. Recent studies conducted at University College Cork, Ireland, suggest that moderate coffee consumption—specifically three to five cups per day—acts as a catalyst for the ‘microbiota-gut-brain axis,’ a complex communication network linking our digestive system to our mental state.

Cultivating a Healthier Microbiome

The study found that regular coffee drinkers harbor higher levels of beneficial bacteria within their gastrointestinal tracts. These ‘good’ microbes play a critical role in aiding digestion and potentially eliminating harmful stomach infections. Interestingly, these positive shifts in gut health were observed regardless of whether the coffee was caffeinated or decaffeinated. This suggests that the bioactive compounds in the coffee bean itself, such as polyphenols, are the primary drivers of gut health rather than the caffeine content.

Mental Health and the Cognitive Edge

The impact of coffee on the brain is equally multifaceted. Researchers noted distinct benefits depending on the type of brew: caffeinated coffee was linked to reduced anxiety, improved attention, and better stress coping, while decaffeinated coffee showed a stronger correlation with enhanced sleep quality and memory. Both varieties, however, were found to lower levels of depression and systemic inflammation. The presence of the anti-inflammatory cytokine IL-10 in coffee drinkers suggests that the beverage may help neutralize free radicals, potentially lowering the long-term risk of cellular damage and certain cancers.

A Complex Beverage for a Complex System

While coffee can cause a temporary spike in blood pressure, the study reinforces that it does not increase the risk of long-term hypertension in healthy individuals. The most intriguing takeaway is that coffee improves mood independently of cortisol levels, meaning its stress-reducing effects work through unique biological pathways. By supporting the gut microbiome and reducing inflammation, coffee serves as a holistic tool for metabolic and psychological wellness, proving that your daily habit is doing much more than just keeping you awake.

Continue Reading

Africa

Deadly Bundibugyo Outbreak in Congo Outpacing Global Response as Deaths Surge

The DRC’s Ebola Bundibugyo outbreak is outpacing global efforts with 220 dead. Lack of vaccines, funding cuts, and conflict create a perfect storm for catastrophe.

Published

6 days ago

on

May 28, 2026

By

A Race Against Time in Ituri

The Democratic Republic of Congo is facing a catastrophic escalation in its latest Ebola outbreak, as health officials warn that the virus is spreading at a \”breakneck speed\” that has already overwhelmed international response efforts. Centered in the volatile Ituri province, the outbreak involves the rare Bundibugyo strain—a variant for which there is currently no approved vaccine or effective medical treatment. According to the World Health Organization (WHO), the crisis has already claimed an estimated 220 lives out of 900 suspected cases, with the virus now confirmed to have crossed the border into neighboring Uganda.

The Critical Gap in Contact Tracing

Leaked documents from a high-level coordination meeting between the WHO and the Africa Centres for Disease Control and Prevention (Africa CDC) reveal a terrifying reality: the response is weeks behind the virus’s trajectory. As of last week, only 7 percent of the over 1,200 identified contacts of suspected patients had been tracked. That number of potential exposures has since risen to more than 2,000, yet the majority remain unmonitored. Experts point out that the virus circulated undetected for six weeks before the first official report, giving it a massive head start in a region already destabilized by conflict.

A Perfect Storm of Funding and Fear

The global health response is struggling under the weight of several systemic failures. The withdrawal of the United States from the WHO and significant cuts to international aid have left a leadership vacuum and a shortage of essential resources, from fuel for transport vehicles to specialized diagnostic tests. Locally, health workers face violent resistance; hospitals have been attacked and isolation units burned by communities wary of outside intervention. This mistrust, coupled with the absence of modern vaccines, has forced medical teams like Mdecins Sans Frontires to return to the \”basics\” of containment used decades ago.

Lessons from the Past

Comparison to the devastating 2014-2016 West African epidemic is inevitable. Epidemiologists warn that unless funding and personnel increase immediately, the current situation in the DRC could mirror the tragedy of the past, where fear led families to hide the sick, further fueling the contagion. With healthcare workers already among the casualties, every day without a fully resourced response allows the virus to claim more ground in one of the world’s most vulnerable regions.

Continue Reading

Health

The Strategic Edge: Why Sleep Is the Executive’s Most Underutilized Asset

Discover why top executives are prioritizing sleep as a strategic tool for better decision-making, cognitive performance, and long-term brain health.

Published

6 days ago

on

May 28, 2026

By

The Biological Cost of High-Performance Leadership

In the high-stakes world of corporate leadership, sleep is often viewed as a luxury or a sign of weakness. However, emerging research and insights from experts like Dr. Matthew Walker, author of Why We Sleep, suggest that sleep is actually the most effective daily reset available to the human brain. While many executives believe they can function on four to six hours of rest, the biological reality is far more demanding. Less than 1% of the population carries the rare DEC2 genetic variant that allows for true high-level performance on minimal rest; for everyone else, sleep deprivation is a direct tax on cognitive output.

The Glymphatic System: Your Brain’s Nightly Waste Removal

One of the most critical functions of sleep occurs through the glymphatic system, a waste-clearance mechanism that operates at ten times its normal capacity during deep sleep. During this period, the brain is flooded with cerebrospinal fluid to flush out toxic metabolic byproducts, such as amyloid-beta, which has been linked to Alzheimer’s disease. For a CEO, operating on five hours of sleep means entering critical board meetings or negotiations with yesterday’s neural waste still cluttering their cognitive processors. This disruption directly suppresses brain networks governing memory, focus, and emotional intelligence.

The Paradox of Self-Assessment

A significant risk for leaders is the sleep paradox: the more sleep-deprived an individual becomes, the less accurately they can judge their own level of impairment. A landmark study published in the journal Sleep found that individuals restricted to six hours of rest for two weeks developed cognitive deficits equivalent to two full nights of total sleep deprivation. Remarkably, these participants reported feeling only slightly tired, demonstrating a dangerous disconnect between subjective feeling and objective performance. This lack of self-awareness can lead to poor hiring decisions and flawed capital allocation.

Sleep as a Strategic Tool

Modern titans of industry, such as Jeff Bezos, have famously prioritized eight hours of sleep to preserve the cognitive state required for high-leverage decision-making. During slow-wave sleep, the brain consolidates information and extracts patterns from complex data sets, allowing leaders to find connections that others miss. Ultimately, the difference between a good decision and a trajectory-shifting great one is often found in the quality of the leader’s rest. For today’s executive, sleep isn’t just maintenance; it is a competitive advantage.

Continue Reading

Trending